Earnings Ahead

AMGN - Amgen Inc

269.98 0.6 0.22

Amgen Inc

Amgen Inc

About

Profile

Amgen is one of the world’s leading biotechnology companies. Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses.


Headquarters

Thousand Oaks, California, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

AMGN



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Amgen’s obesity prospects in focus ahead of Q4 results
  • Amgen weight loss drug shows promising early data
  • Earnings week ahead: Alibaba, PepsiCo, Disney, Palantir, McDonalds, Ford and more
  • Catalyst watch: Alibaba earnings, World Defense Show, Fed speakers unleashed and Super Bowl buzz
  • U.S. govt. opens bids in Medicare drug price negotiations
  • Big Pharma earnings season in spotlight amid positive sentiment
  • PBMs ramp up lobbying efforts amid growing public scrutiny
  • FDA issues boxed warning for Amgen's osteoporosis drug
  • Honeywell's quantum computing firm valued at $5B after new fund raising round
  • Amgen may be evaluating Cytokinetics bid; CYTK wants $130-$145 a share - report (update)
  • Amgen in pact with Xeris Biopharma for Tepezza injectable
  • Florida wins FDA nod for mass drug imports from Canada (update)
  • Morgan Stanley positive on healthcare services despite election year
  • Pharma and biotech deal values spike 35% in 2023: report
  • Amgen says FDA declined full approval for lung cancer drug Lumakras
  • Amgen upgraded by BMO on underappreciated opportunity in obesity/metabolic space
  • Dividend Roundup: Alibaba, Amgen, AT&T, Southwest Airlines, and more
  • AbbVie, Amgen among firms targeted for latest Medicare inflation penalties
  • Amgen names former Novartis exec James Bradner as chief scientific officer
  • Amgen gets FDA priority review for small cell lung cancer drug

Earnings History

Date EPS / Forecast Revenue / Forecast
February 7, 2022 4.36 / 4.07 6.85B / 6.88B
November 2, 2021 4.67 / 4.29 6.71B / 6.67B Beat!
August 3, 2021 4.38 / 4.09 6.53B / 6.46B Beat!
April 27, 2021 3.7 / 4.05 5.9B / 6.26B
February 2, 2021 3.81 / 3.36 6.63B / 6.57B Beat!
October 28, 2020 4.37 / 3.93 6.42B / 6.39B Beat!
July 28, 2020 4.25 / 3.82 6.21B / 6.19B Beat!
April 30, 2020 4.17 / 3.74 6.16B / 6B Beat!
January 30, 2020 3.64 / 3.41 6.2B / 6.03B Beat!
October 29, 2019 3.66 / 3.53 5.74B / 5.63B Beat!
July 30, 2019 3.97 / 3.59 5.87B / 5.69B Beat!
April 30, 2019 3.56 / 3.48 5.56B / 5.53B Beat!
January 29, 2019 3.42 / 3.27 6.23B / 5.84B Beat!
October 30, 2018 3.69 / 3.45 5.9B / 5.78B Beat!
July 26, 2018 3.83 / 3.54 6.06B / 5.72B Beat!
April 24, 2018 3.47 / 3.22 5.55B / 5.43B Beat!
February 1, 2018 2.89 / 3.03 5.80B / 5,828M
October 25, 2017 3.27 / 3.11 5.77B / 5,756M Beat!
July 25, 2017 3.27 / 3.11 5.81B / 5.67B Beat!
April 26, 2017 3.15 / 3.11 5.46B / - Beat!
February 2, 2017 2.89 / 2.99 5.97B / 5.77B Beat!
October 27, 2016 3.02 / 2.81 5.81B / 5.71B Beat!
Date Price Open High Low Vol Change
Apr 26 269.98 265.72
271.68
265.72
2.4M 0.22%
Apr 25 269.38 273.45
274.35
267.24
1.8M -1.33%
Apr 24 273.01 270.63
274.86
269.64
2.5M -0.19%
Apr 23 273.54 272.14
274.48
271.05
2.5M 0.60%
Apr 22 271.91 269.84
273.14
269.84
2.2M 1.11%
 
Apr 19 268.93 264.63
269.38
260.68
3.4M 2.35%
Apr 18 262.75 265.64
265.92
262.58
2.1M -0.5%
Apr 17 264.07 267.54
268.77
263.39
2.2M -0.59%
Apr 16 265.64 266.83
267.51
263.81
2.0M 0.05%
Apr 15 265.51 269.93
270.93
264.35
1.6M -0.66%
Apr 12 267.28 268.77
269.3
266.17
2.1M -1.01%
Apr 11 270 270.22
273
268.45
2.2M 1.33%
Apr 10 266.45 267.96
268.38
264.63
1.9M -1.45%
Apr 9 270.36 270.19
271.29
268.58
1.8M 0.43%
Apr 8 269.2 269.48
270.21
267.55
1.8M -0.28%
Apr 5 269.95 265.9
273.07
265.08
2.3M 0.69%
Apr 4 268.09 276.05
276.73
267.75
2.5M -2.31%
Apr 3 274.42 275.69
276.47
273.68
1.7M -0.65%
Apr 2 276.21 283.34
283.91
276.04
2.2M -2.41%
Apr 1 283.04 282.11
283.83
279
1.9M -0.45%
Mar 28 284.32 287.86
288.57
284.21
2.3M -0.69%
Mar 27 286.3 284.22
286.82
282.55
2.3M 1.61%
Mar 26 281.77 282.15
284.5
280.7
3.3M 0.34%
Mar 25 280.82 276.43
281.33
275.41
3.0M 1.68%
Mar 22 276.17 277.39
278.29
275.1
2.3M -0.28%
Mar 21 276.95 274.63
277.92
274.39
2.5M 1.43%
Mar 20 273.05 271.21
273.08
269.24
2.6M 0.49%
Mar 19 271.73 270.18
273.16
269.51
3.0M 0.31%
Mar 18 270.9 270
273.58
269.21
3.6M 0.76%
Mar 15 268.87 272.09
275.18
268.17
8.8M -0.98%
Mar 14 271.54 276.84
277.23
270.45
2.4M -1.61%
Mar 13 275.99 278.18
278.56
275.21
1.6M -0.2%
Mar 12 276.54 276.85
278.15
274.14
1.7M 0.43%
Mar 11 275.36 274.51
278.19
272.99
1.9M 0.59%
Mar 8 273.75 272.81
276.56
272.01
2.3M 0.33%
Mar 7 272.86 276.3
276.81
269.58
4.1M -1.35%
Mar 6 276.59 275.38
278.97
274.55
2.2M -0.02%
Mar 5 276.65 279.62
279.75
275.02
3.1M -0.98%
Mar 4 279.39 283.26
285.89
277.65
2.5M -0.34%
Mar 1 280.33 276.5
281.92
274.88
3.8M 2.37%
Feb 29 273.83 278.52
279.83
273.43
5.7M -1.31%
Feb 28 277.46 278.99
280.43
277.09
3.0M -0.37%
Feb 27 278.49 279.1
281.22
277.09
3.3M -2.75%
Feb 26 286.37 288.28
289.87
285.42
2.4M -0.97%
Feb 23 289.18 286.52
292.24
286.01
2.5M 1.40%
Feb 22 285.18 282.48
285.72
281.3
3.0M 0.61%
Feb 21 283.46 284.84
285.78
280.8
1.9M -0.02%
Feb 20 283.51 283.85
285.3
280.55
3.4M -0.07%
Feb 16 283.7 287.71
287.71
283.27
3.6M -1.86%
Feb 15 289.07 287.88
290.35
285.6
2.9M -0.34%
Feb 14 290.07 289.88
290.87
287.55
2.6M -0.14%
Feb 13 290.48 294.61
295.52
286.89
3.6M -1.34%
Feb 12 294.43 289.97
294.6
288.86
3.3M 1.14%
Feb 9 291.12 294.85
295
289.71
3.3M -1.27%
Feb 8 294.85 297
298
288.78
5.9M -0.34%
Feb 7 295.87 315.51
315.51
295.27
8.3M -6.39%
Feb 6 316.07 325.4
326.96
314.75
5.8M -1.83%
Feb 5 321.97 323.53
329.72
317.71
3.6M -0.38%
Feb 2 323.19 323.64
325.77
320.75
2.6M -0.42%
Feb 1 324.56 314.5
324.82
313.7
3.5M 0%